A critical breakthrough in cancer investigation is emerging with the use of nanobodies to re-engage mutated p53. This vital malignant inhibitor protein is frequently inactivated in various types of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research